Welcome to our dedicated page for Charles & Colvard news (Ticker: CTHR), a resource for investors and traders seeking the latest updates and insights on Charles & Colvard stock.
Charles & Colvard, Ltd. reports developments for a fine jewelry company focused on moissanite and lab-grown diamond jewelry. Company updates center on its Forever One moissanite and Caydia lab-grown diamond brands, online and wholesale distribution, social-commerce partnerships, and supply-chain relationships for lab-grown diamonds.
News about CTHR also covers public-company status matters, including Nasdaq compliance and delisting updates, OTC trading context, shareholder and board governance, arbitration developments, strategic financing, and restructuring-related corporate actions. The company’s communications often link product expansion and digital commerce with capital structure and reporting-status events.
Charles & Colvard (Nasdaq: CTHR), a renowned fine jewelry company, announced a one-for-ten (1:10) reverse stock split of its common stock. Effective May 17, 2024, this move aims to comply with Nasdaq’s $1.00 minimum bid price requirement. Post-split, the number of shares will reduce from approximately 30 million to 3 million, with no fractional shares issued. The company's ticker remains 'CTHR'. Shareholders approved the proposal on May 7, 2024, and the North Carolina Secretary of State filed the Articles of Amendment on May 14, 2024. The company’s stock options and equity awards will adjust proportionately.
Charles & Colvard, a fine jewelry company specializing in moissanite and lab-grown diamonds, reported third-quarter fiscal year 2024 financial results. Despite a challenging quarter, the company remains focused on growth through strategic initiatives and technology investments. They saw growth in repeat customers and positive responses to new products and marketing efforts. The company introduced new gemstone brands, expanded product lines, and partnered with a celebrity brand ambassador. However, they experienced a 21% decrease in net sales, primarily in the Traditional segment. Gross profit margin declined to 23%, and operating expenses increased by 13%. The net loss was $3.6 million for the quarter, with cash and inventory decreasing.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.